We used the Du Pont radioimmunoassay kit for soluble Legionella pneumophila serogroup 1 antigenuria (Du Pont Co., Wilmington, Del.) to test 422 urine samples from patients with and without Legionnaires disease (LD). The urine specimens were collected from 23 patients with culture-proven LD and from 346 patients without LD. L. pneumophila serogroup 1 was isolated from 14 patients with culture-proven LD, and other L. pneumophila serogroups or other Legionella species were isolated from 9 patients; 58 urine specimens were tested from these 23 patients. The non-LD group was composed of 75 bacteremic patients (35 gram-negative and 40 gram-positive bacteremias), 7 patients with candidemia, 48 patients with non-LD pneumonia, 90 patients with gram-negative bacteriuria (>105 CFU/mI), 23 patients with gram-positive bacteriuria (>105 CFU/ml), 14 patients with candiduria (>105 CFU/ml), and 89 outpatients with negative urine cultures. All tests were performed in duplicate, including positive and negative controls. Sample results with values .3.0 times those of the negative controls were considered positive for L. pneumophila serogroup 1 antigenuria. The average sample-to-negative ratios were 19.1 for the L. pneumophila serogroup 1 specimens, and 1.0 for both the non-serogroup 1 legionella group and the non-LD specimens. All but one of the patients who were culture positive for L. pneumophila serogroup 1 had at least one specimen positive for serogroup 1 antigenuria; none of the non-L. pneumophila serogroup 1 patients had a positive urine test. The test was highly specific (100%) and sensitive (93%) for the detection of L. pneumophila serogroup 1 antigenuria. Concentration of urine by vacuum evaporation increased test sensitivity without apparently affecting specificity.
Several rapid methods have been described for the laboratory diagnosis of Legionnaires disease (LD). One of the earliest described methods was detection of a soluble Legionella pneumophila antigen in urine (1, 3, 15) . These antigens have been detected by latex agglutination assays (10) , reversed passive agglutination (8, 13) , enzyme-linked immunosorbent assays (1, 6, 10, 11, 14, 15) , or radioimmunoassay (RIA) (4-7, 10, 11) . The sensitivities of these tests range from approximately 70 to 100%, depending on the criteria used to define the disease (3) . Assays for L. pneumophila antigenuria have been confined to research laboratories because of the unavailability of a commercial system for performing this test. In the present study, we evaluated a commercial RIA for the detection of L. pneumophila serogroup 1 antigenuria, using specimens from well-defined patient groups.
MATERIALS AND METHODS
Specimens. A total of 422 urine specimens were tested. Of these, 58 specimens were obtained from 23 patients with culture-proven LD, and the remainder of specimens were obtained from hospital inpatients and outpatients who had urine submitted to the clinical microbiology laboratory for routine urine culture ( orescence microscopy (DFA) for serogroup 1; samples from 12 of these patients were positive. A total of 364 urine specimens from 346 patients were used as negative controls. The specimens were taken from patients with well-documented infections and from outpatients being screened for bacteriuria. Pneumonia in this group of patients was defined as the presence of a new radiographic infiltrate and fever. Of the 46 patients with non-LD pneumonia, 13 had pneumonia caused by members of the Enterobacteriaceae, 11 had mixed-flora aspiration pneumonia, 4 had Pseudomonas aeruginosa pneumonia, 8 had pneumonia of unclear etiology, 4 had Haemophilus influenza pneumonia, 4 had fungal pneumonia, and 2 had beta-hemolytic streptococcal pneumonias. Urine specimens collected from the non-LD patients were stored at 5C for up to 7 days before being frozen at -20°C, and the specimens were tested within 2 months of the collection date. Urine specimens were thawed only at the time of testing during this trial; none had been previously thawed.
Assay method. 37 ± 0.5°C. The tube contents were then discarded by aspiration, and the tubes were washed three times with 1-ml volumes of 0.15% NaCi, aspirating after each wash. Radiolabeled detection antibody (100 ,ul) was added to each tube; the tubes were incubated for 1 h in a 37°C water bath, after which the tube contents were aspirated and washed as described above. Radioactivity bound to the tubes was determined by using a gamma scintillation counter (Berthold, Nashua, N.H.), counting for 1 min. The gamma counter was calibrated daily, using a sealed-source 1291 standard; the average counting efficiency was 79%. The ratio of the radioactivity of each sample to that of the mean of the negative-control samples was calculated automatically. Urine samples with sample-to-negative ratios 23.0 were considered positive for L. pneumophila serogroup 1 antigenuria. Two falsely negative urine specimens and some truly negative specimens were concentrated fivefold, using a vacuum evaporator (Speed-Vac; Savant Instruments, Inc., Farmingdale, N.Y.) to determine whether test sensitivity could be enhanced without decreasing specificity. Statistical methods. Descriptive statistics were computed by standard methods (12) . Comparison of mean values was by nonpaired two-tailed t tests (12) , and calculation of type-two error was by the method of Cohen (2) . RESULTS L. pneumophila serogroup 1 antigenuria was detected in at least one unconcentrated urine specimen from all but one patient with LD caused by L. pneumophila serogroup 1 (sensitivity, 93%), whereas there were no positive urine specimens from any other LD or non-LD patient. In the one L. pneumophila serogroup 1 patient for whom the antigenuria test was negative (average ratio, 1.9) , only one specimen of urine was available. After fivefold concentration of the urine, the ratio rose to 4.2.
Mean sample-to-negative ratios were significantly different in L. pneumophila serogroup The mean and median sample-to-negative values for the non-LD group of urine specimens was 1.0, with a range of 0.5 to 1.8, standard deviation of 0.2, and 99% confidence interval of 0.9 to 1.0. No difference was apparent between the ratios of urine specimens from non-L. pneumophila serogroup 1 LD patients and those of urine specimens from non-LD patients (P > 0.5, 1 -P = 0.17, with a2 = 0.05).
None of the duplicate pairs of specimens gave discrepant results for either positive or negative samples.
More than one urine specimen was available from nine patients with L. pneumophila serogroup 1 infection. These specimens were collected at various times for up to 15 days after the onset of disease. In all but two of the nine patients with L. pneumophila serogroup 1 infections, antigenuria was detected up to the last specimen of the series received. One of the patients whose specimen results were an exception to this result had a series of urine specimens available up to 15 days after onset of disease; antigenuria was detectable until the 14th day. This respiratory secretions of this patient were culture positive for L. pneumophila serogroup 1 on hospital admission, 7 days after initiation of symptoms, but were DFA negative. The highest average ratio for this series of urine specimens was only 4.2, and on the l5th day it was 2.3. The other patient had three urine specimens collected during the course of illness; urine specimens collected on hospital days 3 and 5 were both positive, with ratios of 3.7 and 5.6, respectively, whereas a urine specimen collected on day 4 was negative, with a ratio of 2.5. Fivefold concentration of the urine specimen yielding a test ratio of 2.5 resulted in a ratio of 3.8. The respiratory tract secretions from the second patient were culture positive for L. pneumophila serogroup 1 on admission and negative thereafter; DFA results for the same secretions were positive for L. pneumophila serogroup 1 for all specimens, including one specimen examined on day 6. Except for urine specimens from the two patients discussed above, the values for the mean sample-to-negative ratios within each patient series did not vary significantly among specimens during the period of observation.
In the subgroup of patients with non-L. pneumophila serogroup 1 LD, a series of urine specimens was available from eight of nine patients. All 28 specimens tested were negative for L. pneumophila serogroup 1 antigen, with ratios ranging from 0.6 to 1.6. The highest values were found in the L. pneumophila serogroup 9 subgroup (range 0.9 to 1.6, mean 1.3), which were not significantly different from the ratios of the other non-L. pneumophila serogroup 1 group urine specimens.
Fivefold concentration of three truly negative urine specimens yielded ratios below 3.0. One specimen collected from a patient with LD caused by L. pneumophila serogroup 9 had a preconcentration ratio of 1.6; the value was 1.4 postconcentration. Another specimen collected from a patient with a urinary tract infection had preconcentration and postconcentration ratios of 1.8 and 1.1, respectively. The preconcentration ratio of a urine specimen collected from a patient with non-LD pneumonia was 0.9; the postconcentration value was 1.2.
The assay took about 3 h to complete for processing 25 (10, 11) , we had no false-positive results (specificity, 100%). Sathapatayavongs and colleagues found three falsepositive results in 178 control urine samples tested with an enzyme-linked immunosorbent assay, all of which became negative after the specimens were boiled; the same specimens were negative when tested by RIA even before being heated (11) . In a separate study, the same group of investigators found one false-positive specimen in 161 negative control urine specimens tested by latex, enzyme-linked immunosorbent assay, and RIA; all three assay types produced a false-positive test with this specimen. In this case, culture and DFA results were negative, but serological tests were not done (10) . In an earlier evaluation of RIA, Kohler and colleagues (7) found one probable false-positive specimen among 241 negative-control urine specimens that they did not include in the study due to lack of diagnostic data. In a retrospective study performed by the same group, no false-positive results were obtained among 498 negative urine specimens tested by RIA (3 In all cases, culture should be used in addition to urine assay, for epidemiological purposes and for optimal sensitivity. Since antigenuria may persist for prolonged periods after treatment, as shown in this study and by others (6), it will always be possible that a positive test represents remote pneumonia rather than an acute illness. Regardless, the test will be of considerable benefit in patients not able to produce sputum for culture and for those with negative cultures because of antimicrobial therapy.
